ACETO CORP
adicetbio.comNo Longer Reporting
The company has not filed an annual or quarterly report since its Q2 FY2019 10-Q, filed Feb 20, 2019. Its latest SEC filing is a 4 from Oct 3, 2019.
10-Q for Q2 FY2019, filed Feb 20, 2019
The sections below describe the company as of the FY2018 annual report.
What Did They Do?
Distributed generic medicines, nutraceutical and pharmaceutical ingredients, and specialty and agricultural chemicals to pharmaceutical, agricultural and industrial companies.
10-K for FY2018, filed Sep 28, 2018Aceto Corporation, together with its consolidated subsidiaries, are referred to herein collectively as “Aceto”, “the Company”, “we”, “us”…View ↗
Products that fall within the Human Health segment include finished dosage form generic drugs and nutraceutical products. Aceto sells…View ↗
Aceto supplies the raw materials used in the production of nutritional and packaged dietary supplements, including vitamins, amino acids…View ↗
We supply APIs to many of the major generic drug companies, who we believe view Aceto as a valued partner in their effort to develop and…View ↗
Aceto has long been a supplier of pharmaceutical intermediates, the complex chemical compounds that are the building blocks used in…View ↗
Who Were Their Customers?
Its customers included companies in health, agriculture and industrial chemicals, ranging from small trading companies to Fortune 500 companies. Generic medicines went to wholesalers, chain drug stores, distributors and mass merchandisers.
10-K for FY2018, filed Sep 28, 2018
10-K for FY2018, filed Sep 28, 2018
One customer accounted for 16% of net sales in fiscal 2018, 12% of net sales in fiscal 2017 and 14% of net sales in fiscal 2016. Another…View ↗
How Were They Changing?
- Net income
-
Sources
10-Q for Q2 FY2019, filed Feb 20, 2019
−$22.4MView ↗
- ▲ +61% (Loss)
- vs −$13.9M in Q2 FY2018
-
Oct 1, 2019
Liquidation plan took effect and existing equity was cancelled
The plan’s effective date followed court confirmation; one share was issued to administer the company’s wind-down.
Sources
8-K, filed Oct 1, 2019
On February 19, 2019, Aceto Corporation (the “Company”) and certain of its U.S. subsidiaries (collectively with the Company, the “Debtors”)…View ↗
-
Sep 20, 2019
Bankruptcy court confirmed the liquidation plan
Aceto and certain U.S. subsidiaries had filed for bankruptcy; the plan provided for liquidation of remaining assets and distributions to claim holders.
Sources
8-K, filed Sep 20, 2019
As previously disclosed, on February 19, 2019, Aceto Corporation, a New York corporation (the “Company”), and certain of its U.S.…View ↗
-
Jun 18, 2019
Chief financial officer Rebecca Roof left
Sources
8-K, filed Jun 18, 2019
Rebecca A. Roof, who has served as the chief financial officer of Aceto Corporation (“Aceto”) since April 2018, ceased to serve in that…View ↗
Federal government customers
Its generic-drug business added federal government supply contracts through the Lucid acquisition, alongside sales to wholesalers, chain drug stores, distributors and mass merchandisers.
10-K for FY2015, filed Sep 11, 2015 10-K for FY2018, filed Sep 28, 2018Products that fall within the Human Health segment include finished dosage form generic drugs and nutraceutical products. On April 30…View ↗
Loading...
